Literature DB >> 208435

Distribution of Bovid herpesvirus 2 in calves inoculated intravenously.

G Castrucci, F Frigeri, V Cilli, L Rampichini, S Ranucci, G Poli.   

Abstract

The behavior of Bovid herpesvirus 2 in the skin, lymph nodes, and nervous system of calves injected intravenously with the virus was studied. After a latent phase that lasted up to 40 hours after inoculation, the virus produced a systemic infection which was characterized by primary localization of virus in the skin, lymph nodes, and nervous system. Between postinoculation days 7 and 12, the infection tended to persist in the skin only. The finding of intranuclear inclusions in the pyramidal cells of the cerebral cortex and in the neurons of the superior cervical and stellate ganglia supports the hypothesis that the virus might utilize the structures of the nervous system for its replicative cycle in the calf.

Entities:  

Mesh:

Year:  1978        PMID: 208435

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  5 in total

1.  Bovid herpesvirus 2 latency: failure to recover virus from central sensory nerve ganglia.

Authors:  G J Letchworth; L E Carmichael
Journal:  Can J Comp Med       Date:  1982-01

2.  Sensitivity of bovid herpesvirus 2 replication to temperatures found in the natural host.

Authors:  G J Letchworth; L E Carmichael; H A Greisen
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

3.  Reactivation in calves of Bovid herpesvirus 2 latent infection.

Authors:  G Castrucci; M Ferrari; F Frigeri; S Ranucci; V Cilli; B Tesei; L Rampichini
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

4.  Local tissue temperature: a critical factor in the pathogenesis of bovid herpesvirus 2.

Authors:  G J Letchworth; L E Carmichael
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

5.  The effect of temperature on production and function of bovine interferons.

Authors:  G J Letchworth; L E Carmichael
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.